78 Publications (Page 1 of 4)
2024
Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myeloma. Cancer
. | Journal Article
2023
Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents. Blood
. | Journal Article
Single‐agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM‐2 trial. Cancer
. | Journal Article
2022
GFI1-Dependent Repression of SGPP1 Increases Multiple Myeloma Cell Survival.Petrusca, Daniela N⋅Mulcrone, Patrick L⋅Macar, David A⋅Bishop, Ryan T⋅Berdyshev, Evgeny⋅Suvannasankha, Attaya⋅Anderson, Judith L⋅Sun, Quanhong⋅Auron, Philip E⋅Galson, Deborah L and Roodman, G DavidCancers, vol. 14, (no. 3), February 2, 2022.
| Journal Article
2021
Belantamab Mafodotin for the Treatment of Relapsed/Refractory Multiple Myeloma in Heavily Pretreated Patients: a US Cost-Effectiveness Analysis.Nikolaou, Andreas⋅Ambavane, Apoorva⋅Shah, Anshul⋅Ma, Wenkang⋅Tosh, Jon⋅Kapetanakis, Venediktos⋅Willson, Jenny⋅Wang, Feng⋅Hogea, Cosmina⋅Gorsh, Boris⋅Gutierrez, Ben⋅Sapra, Sandhya⋅Suvannasankha, Attaya and Samyshkin, YevgeniyExpert review of hematology, September 1, 2021.
| Journal Article
Longer term outcomes with single‐agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13‐month follow‐up from the pivotal DREAMM‐2 studyLonial, Sagar⋅Lonial, Sagar⋅Lonial, Sagar⋅Lee, Hans C⋅Lee, Hans C⋅Lee, Hans C⋅Badros, Ashraf⋅Badros, Ashraf⋅Badros, Ashraf⋅Trudel, Suzanne⋅Trudel, Suzanne⋅Trudel, Suzanne⋅Nooka, Ajay K⋅Nooka, Ajay K⋅Nooka, Ajay K⋅Chari, Ajai⋅Chari, Ajai⋅Chari, Ajai⋅Callander, Natalie⋅Callander, Natalie⋅Callander, Natalie⋅Sborov, Douglas⋅Sborov, Douglas⋅Sborov, Douglas⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Weisel, Katja⋅Weisel, Katja⋅Weisel, Katja⋅Voorhees, Peter M⋅Voorhees, Peter M⋅Voorhees, Peter M⋅Womersley, Lynsey⋅Womersley, Lynsey⋅Womersley, Lynsey⋅Baron, January⋅Baron, January⋅Baron, January⋅Piontek, Trisha⋅Piontek, Trisha⋅Piontek, Trisha⋅Lewis, Eric⋅Lewis, Eric⋅Lewis, Eric⋅Opalinska, Joanna⋅Opalinska, Joanna⋅Opalinska, Joanna⋅Gupta, Ira⋅Gupta, Ira⋅Gupta, Ira⋅Cohen, Adam D⋅Cohen, Adam D and Cohen, Adam DCancer, vol. 127, (no. 22), pp. 4198-4212, Nov 2021.
| Journal Article
2020
Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 studyLonial, Sagar⋅Lonial, Sagar⋅Lonial, Sagar⋅Lonial, S.⋅Lonial, Sagar⋅Lonial, Sagar⋅Lonial, Sagar⋅Lee, Hans C⋅Lee, Hans C⋅Lee, Hans C⋅Lee, H.C.⋅Lee, Hans C⋅Lee, Hans C⋅Lee, Hans C⋅Badros, Ashraf⋅Badros, Ashraf⋅Badros, Ashraf⋅Badros, A.⋅Badros, Ashraf⋅Badros, Ashraf⋅Badros, Ashraf⋅Trudel, S.⋅Trudel, Suzanne⋅Trudel, Suzanne⋅Trudel, Suzanne⋅Trudel, Suzanne⋅Trudel, Suzanne⋅Trudel, Suzanne⋅Nooka, Ajay K⋅Nooka, Ajay K⋅Nooka, A.K.⋅Nooka, Ajay K⋅Nooka, Ajay K⋅Nooka, Ajay K⋅Nooka, Ajay K⋅Chari, Ajai⋅Chari, Ajai⋅Chari, Ajai⋅Chari, Ajai⋅Chari, Ajai⋅Chari, Ajai⋅Chari, A.⋅Abdallah, A.-O.⋅Al-Ola, Abdallah⋅Abdallah, Al-Ola⋅Al-Ola, Abdallah⋅Al-Ola, Abdallah⋅Al-Ola, Abdallah⋅Al-Ola, Abdallah⋅Callander, Natalie⋅Callander, Natalie⋅Callander, Natalie⋅Callander, N.⋅Callander, Natalie⋅Callander, Natalie⋅Callander, Natalie⋅Lendvai, Nikoletta⋅Lendvai, Nikoletta⋅Lendvai, Nikoletta⋅Lendvai, Nikoletta⋅Lendvai, N.⋅Lendvai, Nikoletta⋅Lendvai, Nikoletta⋅Sborov, Douglas⋅Sborov, Douglas⋅Sborov, Douglas⋅Sborov, Douglas⋅Sborov, Douglas⋅Sborov, Douglas⋅Sborov, D.⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, A.⋅Weisel, Katja⋅Weisel, Katja⋅Weisel, K.⋅Weisel, Katja⋅Weisel, Katja⋅Weisel, Katja⋅Weisel, Katja⋅Karlin, Lionel⋅Karlin, Lionel⋅Karlin, L.⋅Karlin, Lionel⋅Karlin, Lionel⋅Karlin, Lionel⋅Karlin, Lionel⋅Libby, E.⋅Libby, Edward⋅Libby, Edward⋅Libby, Edward⋅Libby, Edward⋅Libby, Edward⋅Libby, Edward⋅Arnulf, B.⋅Arnulf, Bertrand⋅Facon, T.⋅Facon, Thierry⋅Facon, Thierry⋅Facon, Thierry⋅Facon, Thierry⋅Facon, Thierry⋅Facon, Thierry⋅Hulin, Cyrille⋅Hulin, C.⋅Hulin, Cyrille⋅Hulin, Cyrille⋅Hulin, Cyrille⋅Hulin, Cyrille⋅Hulin, Cyrille⋅Kortüm, K Martin⋅Kortüm, K.M.⋅Rodríguez-Otero, Paula⋅Rodríguez-Otero, Paula⋅Rodríguez-Otero, Paula⋅Rodríguez-Otero, Paula⋅Rodríguez-Otero, P.⋅Rodríguez-Otero, Paula⋅Rodríguez-Otero, Paula⋅Usmani, Saad Z⋅Usmani, S.Z.⋅Usmani, Saad Z⋅Usmani, Saad Z⋅Usmani, Saad Z⋅Usmani, Saad Z⋅Usmani, Saad Z⋅Hari, Parameswaran⋅Hari, P.⋅Baz, Rachid⋅Baz, Rachid⋅Baz, Rachid⋅Baz, R.⋅Baz, Rachid⋅Baz, Rachid⋅Baz, Rachid⋅Quach, Hang⋅Quach, Hang⋅Quach, Hang⋅Quach, Hang⋅Quach, H.⋅Quach, Hang⋅Quach, Hang⋅Moreau, Philippe⋅Moreau, Philippe⋅Moreau, Philippe⋅Moreau, Philippe⋅Moreau, Philippe⋅Moreau, Philippe⋅Moreau, P.⋅Voorhees, Peter M⋅Voorhees, Peter M⋅Voorhees, Peter M⋅Voorhees, Peter M⋅Voorhees, Peter M⋅Voorhees, Peter M⋅Voorhees, P.M.⋅Gupta, Ira⋅Gupta, Ira⋅Gupta, Ira⋅Gupta, Ira⋅Gupta, I.⋅Gupta, Ira⋅Gupta, Ira⋅Hoos, Axel⋅Hoos, Axel⋅Hoos, Axel⋅Hoos, A.⋅Hoos, Axel⋅Hoos, Axel⋅Hoos, Axel⋅Zhi, Eric⋅Zhi, Eric⋅Zhi, Eric⋅Zhi, E.⋅Zhi, Eric⋅Zhi, Eric⋅Zhi, Eric⋅Baron, January⋅Baron, January⋅Baron, January⋅Baron, January⋅Baron, J.⋅Baron, January⋅Baron, January⋅Piontek, Trisha⋅Piontek, Trisha⋅Piontek, T.⋅Piontek, Trisha⋅Piontek, Trisha⋅Piontek, Trisha⋅Piontek, Trisha⋅Lewis, Eric⋅Lewis, E.⋅Lewis, Eric⋅Lewis, Eric⋅Lewis, Eric⋅Lewis, Eric⋅Lewis, Eric⋅Jewell, Roxanne C⋅Jewell, Roxanne C⋅Jewell, Roxanne C⋅Jewell, R.C.⋅Jewell, Roxanne C⋅Jewell, Roxanne C⋅Jewell, Roxanne C⋅Dettman, Elisha J⋅Dettman, Elisha J⋅Dettman, Elisha J⋅Dettman, Elisha J⋅Dettman, Elisha J⋅Dettman, Elisha J⋅Dettman, E.J.⋅Popat, R.⋅Popat, Rakesh⋅Popat, Rakesh⋅Popat, Rakesh⋅Popat, Rakesh⋅Popat, Rakesh⋅Popat, Rakesh⋅Esposti, Simona Degli⋅Esposti, S.D.⋅Opalinska, Joanna⋅Opalinska, J.⋅Opalinska, Joanna⋅Opalinska, Joanna⋅Opalinska, Joanna⋅Opalinska, Joanna⋅Opalinska, Joanna⋅Richardson, Paul⋅Richardson, Paul⋅Richardson, Paul⋅Richardson, Paul⋅Richardson, Paul⋅Richardson, Paul⋅Richardson, P.⋅Cohen, Adam D⋅Cohen, A.D.⋅Cohen, Adam D⋅Cohen, Adam D⋅Cohen, Adam D⋅Cohen, Adam D and Cohen, Adam DThe Lancet Oncology, vol. 21, (no. 2), pp. 221, February 2020.
| Journal Article
2019
Acquired Factor X Deficiency in Patients With Primary Light Chain AmyloidosisDejhansathit, Siroj and Suvannasankha, AttayaJournal of Investigative Medicine High Impact Case Reports, vol. 7, pp. 2324709619832332, 20190300.
| Journal Article
2018
Acute lymphoblastic leukaemia with osteolytic bone lesions: diagnostic dilemmaAngsubhakorn, Natthapon and Suvannasankha, AttayaBMJ Case Reports, vol. 2018, Aug 11, 2018.
| Journal Article
Cold agglutinin-mediated autoimmune haemolytic anaemia associated with diffuse large B cell lymphomaWongsaengsak, Sariya⋅Czader, Magdalena and Suvannasankha, AttayaBMJ Case Reports, vol. 2018, Jul 10, 2018.
| Journal Article
Consecutive epigenetically-active agent combinations act in ID1-RUNX3-TET2 and HOXA pathways for Flt3ITD+ve AMLSayar, Hamid⋅Sayar, Hamid⋅Sayar, H.⋅Sayar, Hamid⋅Sayar, Hamid⋅Liu, Yan⋅Liu, Yan⋅Liu, Y.⋅Liu, Yan⋅Liu, Yan⋅Gao, R.⋅Gao, Rui⋅Gao, Rui⋅Gao, Rui⋅Gao, Rui⋅Zaid, Mohammad Abu⋅Zaid, M.A.⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Cripe, Larry D⋅Cripe, Larry D⋅Cripe, Larry D⋅Cripe, L.D.⋅Cripe, Larry D⋅Weisenbach, Jill⋅Weisenbach, Jill⋅Weisenbach, J.⋅Weisenbach, Jill⋅Weisenbach, Jill⋅Sargent, Katie J⋅Sargent, Katie J⋅Sargent, K.J.⋅Sargent, Katie J⋅Sargent, Katie J⋅Nassiri, Mehdi⋅Nassiri, M.⋅Nassiri, Mehdi⋅Nassiri, Mehdi⋅Nassiri, Mehdi⋅Li, Lang⋅Li, Lang⋅Li, Lang⋅Li, Lang⋅Li, L.⋅Konig, Heiko⋅Konig, Heiko⋅Konig, Heiko⋅Konig, Heiko⋅Konig, H.⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, A.⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Pan, Feng⋅Pan, Feng⋅Pan, Feng⋅Pan, Feng⋅Pan, F.⋅Shanmugam, Rajasubramaniam⋅Shanmugam, Rajasubramaniam⋅Shanmugam, Rajasubramaniam⋅Shanmugam, R.⋅Shanmugam, Rajasubramaniam⋅Goswami, Chirayu⋅Goswami, Chirayu⋅Goswami, Chirayu⋅Goswami, C.⋅Goswami, Chirayu⋅Kapur, Reuben⋅Kapur, Reuben⋅Kapur, Reuben⋅Kapur, R.⋅Kapur, Reuben⋅Xu, Mingjiang⋅Xu, Mingjiang⋅Xu, Mingjiang⋅Xu, M.⋅Xu, Mingjiang⋅Scott Boswell, H.⋅Boswell, H Scott⋅Boswell, H Scott⋅Boswell, H Scott and Boswell, H ScottOncotarget, vol. 9, (no. 5), pp. 5715, 2018-Jan-19.
| Journal Article
Multiple ‘doughnut’ granulomas in a liver transplant patient with CMV reactivationDejhansathit, Siroj⋅Miller, Adam Michael and Suvannasankha, AttayaBMJ Case Reports, vol. 11, (no. 1), pp. e227252, 20181200.
| Journal Article
Proteomic Characterization of Plasma Cells from Patients with Multiple MyelomaSuvannasankha, Attaya⋅Suvannasankha, Attaya⋅Crean, Colin D⋅Crean, Colin D⋅Leyes, Heather M⋅Leyes, Heather M⋅Wongsaengsak, Sariya⋅Wongsaengsak, Sariya⋅Qi, Guihong⋅Qi, Guihong⋅Won Kim, Jong⋅Won Kim, Jong⋅Wang, Mu and Wang, MuJournal of Proteomics & Bioinformatics, vol. 11, (no. 1), 2018-00-00.
| Journal Article
PTHrP May Contribute to Cachexia Accompanying Multiple Myeloma Bone DiseaseSuvannasankha, Attaya⋅Suvannasankha, Attaya⋅Crean, Colin⋅Crean, Colin⋅Ochoa, Isaac Carrera⋅Ochoa, Isaac Carrera⋅Roodman, G David⋅Roodman, G David⋅Chirgwin, John and Chirgwin, JohnBlood, vol. 132, (no. Supplement 1), pp. 4450, 2018-11-29.
| Journal Article
Testicular plasmacytoma misdiagnosed as orchitisSchiavo, Christopher⋅Mann, Steven Alexander⋅Mer, Jesse and Suvannasankha, AttayaBMJ Case Reports, vol. 2018, Jun 2, 2018.
| Journal Article
The Role of Semaphorin 4D in Bone Remodeling and Cancer MetastasisLontos, Konstantinos⋅Lontos, Konstantinos⋅Adamik, Juraj⋅Adamik, Juraj⋅Tsagianni, Anastasia⋅Tsagianni, Anastasia⋅Galson, Deborah L⋅Galson, Deborah L⋅Chirgwin, John M⋅Chirgwin, John M⋅Suvannasankha, Attaya and Suvannasankha, AttayaFrontiers in Endocrinology, vol. 9, pp. 322, 2018-06-19.
| Journal Article
2017
Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myelomaChari, Ajai⋅Suvannasankha, Attaya⋅Fay, Joseph W⋅Arnulf, Bertrand⋅Kaufman, Jonathan L⋅Ifthikharuddin, Jainulabdeen J⋅Weiss, Brendan M⋅Krishnan, Amrita⋅Lentzsch, Suzanne⋅Comenzo, Raymond⋅Wang, Jianping⋅Nottage, Kerri⋅Chiu, Christopher⋅Khokhar, Nushmia Z⋅Ahmadi, Tahamtan and Lonial, SagarBlood, vol. 130, (no. 8), pp. 981, 2017-08-24.
| Journal Article
Multifocal myeloid sarcomas: a rare presentation of AMLAngsubhakorn, Natthapon and Suvannasankha, AttayaBMJ Case Reports, vol. 2017, Oct 4, 2017.
| Journal Article
Phase 1b Study of Daratumumab plus Pomalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma (RRMM) with ≥2 Prior Lines of TherapyChari, Ajai⋅Suvannasankha, Attaya⋅Fay, Joseph⋅Arnulf, Bertrand⋅Kaufman, Jonathan⋅Ifthikharuddin, Jainulabdeen⋅Weiss, Brendan⋅Krishnan, Amrita⋅Lentzsch, Suzanne⋅Comenzo, Ray⋅Wang, Jim⋅Masterson, Tara⋅Nottage, Kerri⋅Schecter, Jordan⋅Chiu, Christopher⋅Khokhar, Nushmia⋅Ahmadi, Tahamtan and Lonial, SagarClinical Lymphoma, Myeloma & Leukemia, vol. 17, (no. 1), pp. e15, 2017.
| Journal Article
Semaphorin 4D to suppress bone formation in multiple myelomaLontos, Konstantinos⋅Adamik, Juraj⋅Zhang, Peng⋅Sun, Quanhong⋅Roodman, David⋅Suvannasankha, Attaya and Galson, Deborah LynnJournal of Clinical Oncology, vol. 35, (no. 15_suppl), pp. 8039, 2017-05-20.
| Journal Article
2016
Cell adhesion molecule CD166 drives malignant progression and osteolytic disease in multiple myeloma.Xu, Linlin⋅Xu, Linlin⋅Mohammad, Khalid S⋅Mohammad, Khalid S⋅Wu, Hao⋅Wu, Hao⋅Crean, Colin⋅Crean, Colin⋅Poteat, Bradley⋅Poteat, Bradley⋅Cheng, Yinghua⋅Cheng, Yinghua⋅Cardoso, Angelo A⋅Cardoso, Angelo A⋅Machal, Christophe⋅Marchal, Christophe C⋅Hanenberg, Helmut⋅Hanenberg, Helmut⋅Abonour, Rafat⋅Abonour, Rafat⋅Kacena, Melissa A⋅Kacena, Melissa A⋅Chirgwin, John M⋅Chirgwin, John⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Srour, Edward F and Srour, Edward FCancer research, September 7, 2016.
| Journal Article
Multifocal Gastric Ulcers Caused by Diffuse Large B Cell Lymphoma in a Patient With Significant Weight LossGromski, Mark A⋅Gromski, Mark A⋅Gromski, Mark A⋅Gromski, Mark A⋅Peng, Jennifer L⋅Peng, Jennifer L⋅Peng, Jennifer L⋅Peng, Jennifer L⋅Zhou, Jiehao⋅Zhou, Jiehao⋅Zhou, Jiehao⋅Zhou, Jiehao⋅Masuoka, Howard C⋅Masuoka, Howard C⋅Masuoka, Howard C⋅Masuoka, Howard C⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Liangpunsakul, Suthat⋅Liangpunsakul, Suthat⋅Liangpunsakul, Suthat and Liangpunsakul, SuthatJournal of Investigative Medicine High Impact Case Reports, vol. 4, (no. 4), pp. 2324709616683721, 20161200.
| Journal Article
Regulation of Osteoblast Function in Myeloma Bone Disease By Semaphorin 4DSuvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Crean, Colin D⋅Crean, Colin D⋅Crean, Colin D⋅Crean, Colin D⋅Tompkins, Douglas R⋅Tompkins, Douglas R⋅Tompkins, Douglas R⋅Tompkins, Douglas R⋅Delgado Calle, Jesus⋅Delgado-Calle, Jesus⋅Delgado-Calle, Jesus⋅Delgado-Calle, Jesus⋅Bellido, Teresita M⋅Bellido, Teresita M⋅Bellido, Teresita M⋅Bellido, Teresita M⋅Roodman, G. David⋅Roodman, G. David⋅Roodman, G. David⋅Roodman, G. David⋅Chirgwin, John M⋅Chirgwin, John M⋅Chirgwin, John M and Chirgwin, John MBlood, vol. 128, (no. 22), pp. 4439, 2016-12-02.
| Journal Article
2015
FGF23 is elevated in multiple myeloma and increases heparanase expression by tumor cells.Suvannasankha, Attaya⋅Tompkins, Douglas R⋅Edwards, Daniel F⋅Petyaykina, Katarina V⋅Crean, Colin D⋅Fournier, Pierrick G⋅Parker, Jamie M⋅Sandusky, George E⋅Ichikawa, Shoji⋅Imel, Erik A and Chirgwin, John MOncotarget, vol. 6, (no. 23), pp. 19647-19660, August 14, 2015.
| Journal Article
Open-Label, Multicenter, Phase 1b Study of Daratumumab in Combination with Pomalidomide and Dexamethasone in Patients with at Least 2 Lines of Prior Therapy and Relapsed or Relapsed and Refractory Multiple MyelomaChari, Ajai⋅Lonial, Sagar⋅Suvannasankha, Attaya⋅Fay, Joseph W⋅Arnulf, Bertrand⋅Ifthikharuddin, Jainulabdeen J⋅Qin, Xiang⋅Masterson, Tara⋅Nottage, Kerri⋅Schecter, Jordan M⋅Ahmadi, Tahamtan⋅Weiss, Brendan⋅Krishnan, Amrita and Lentzsch, SuzanneBlood, vol. 126, (no. 23), pp. 508, 2015-12-03.
| Journal Article
